TJX Companies CapEx increased by 33.2% to $662.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.2%, from $497.00M to $662.00M. Over 3 years (FY 2022 to FY 2025), CapEx shows an upward trend with a 20.4% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $225.29M | $467.71M | $407.00M | $0.00 | $314.00M | $506.00M | $460.00M | $177.00M | $361.00M | $621.00M | $422.00M | $318.00M | $419.00M | $539.00M | $531.00M | $429.00M | $497.00M | $662.00M |
| QoQ Change | — | +107.6% | -13.0% | -100.0% | — | +61.1% | -9.1% | -61.5% | +104.0% | +72.0% | -32.0% | -24.6% | +31.8% | +28.6% | -1.5% | -19.2% | +15.9% | +33.2% |
| YoY Change | — | — | — | — | +39.4% | +8.2% | +13.0% | — | +15.0% | +22.7% | -8.3% | +79.7% | +16.1% | -13.2% | +25.8% | +34.9% | +18.6% | +33.2% |